As the global biopharmaceutical landscape continues to evolve, the demand for cross-border collaboration and high-value asset integration has never been greater. Protheragen, a premier US-based group specializing in pharmaceutical investment, incubation, and global business development (BD), is pleased to announce its participation in the 2026 ChinaBio® Partnering Forum , held on April 28–29, 2026 at the Kerry Hotel Pudong, Shanghai.
We invite pharmaceutical executives, investors, and biotech innovators to meet with our team to explore how we can accelerate the journey from local discovery to international commercial success.
Whether you are looking to bring innovation into your pipeline or take your proprietary technology to the world stage, Protheragen serves as your strategic catalyst.
For Biotechs: Accelerating the Path “Outbound”
If you have high-quality projects seeking global partnerships or overseas financing, Protheragen provides the expertise and network to facilitate your international journey. Our team understands the nuances of cross-border BD and can help you navigate the complexities of global markets.
For Pharma & Investors: Precision Asset Scouting
For pharmaceutical companies looking to in-license innovative candidates or investment institutions seeking high-value assets, we offer a streamlined gateway to a de-risked and diversified portfolio. We match your specific strategic criteria with our curated list of global projects to find the perfect “fit”.
A Robust Portfolio of High-Potential Assets
Protheragen operates at the intersection of innovation and investment. We manage an extensive pipeline of high-potential pharmaceutical assets across various therapeutic modalities and developmental stages:
We view ChinaBio® 2026 as the starting point for a deeper international dialogue. We invite you to discuss how we can transition the momentum from our meeting in China to the BIO International Convention 2026 in San Diego (June). Leveraging our dual presence in the US and China, we ensure your innovations maintain high-level momentum across the world’s most influential platforms.
Protheragen is officially registered for the forum, and our meeting schedule is now open. We welcome you to reach out and arrange a one-on-one session to discuss potential collaborations.
We look forward to connecting with you in Shanghai and shaping the future of global medicine together.
Protheragen's business is growing rapidly after founded in New York. Our business has evolved from the initial cross-border BD consulting service to encompass segments in equity investment and project incubation.
 |
Protheragen Inc. |
 |
Quick Links |
